Skip to main content

Table 1 Clinical spectrum of beta-lactam hypersensitivity

From: Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology

Gell and Coombs Classification (extended)

Type of immune response

Pathologic characteristics

Clinical symptoms

Type I

IgE

Mast-cell degranulation

Urticaria, anaphylaxis

Type II

IgG and FC receptor

FCR-dependent cell destruction

Blood cell dyscrasia

Type III

IgG and complement or FC receptor

Immune complex deposition

Vasculitis

Type IVa

Th1 (Interferon-γ)

Monocyte activation

Eczema

Type IVb

Th2 (IL-5 and IL-4)

Eosinophilic inflammation

Maculopapular exanthema, bullous exanthema

DRESS (drug reaction with eosinophilia and sytsemic symptoms)

Type IVc

Cytotoxic lymphocytes (perforin and granzyme B)

CD4- or CD8-mediated killing of cells

Macuolopapular exanthema, eczema, bullous exanthema, pustular exanthema

SJS/TEN (Stevens Johnson Syndrome/Toxic Epidermal Necrolysis)

Type IVd

T cells (IL-8)

Neutrophil recruitment and activation

Pustular exanthema

  1. Adapted from ref. [55]
  2. IL Interleukin, Th  T helper